Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,087
Closed -$1.33M 97
2021
Q1
$1.33M Sell
11,087
-2,051
-16% -$243K 0.99% 34
2020
Q4
$1.44M Buy
13,138
+2,342
+22% +$255K 1.11% 34
2020
Q3
$1.18M Sell
10,796
-7,271
-40% -$738K 1.46% 24
2020
Q2
$1.65M Sell
18,067
-982
-5% -$88.8K 1.87% 13
2020
Q1
$1.5M Sell
19,049
-2,004
-10% -$167K 3.61% 11
2019
Q4
$1.83M Sell
21,053
-120
-0.6% -$10.1K 1.79% 24
2019
Q3
$1.77M Sell
21,173
-7,442
-26% -$632K 1.77% 24
2019
Q2
$2.41M Buy
+28,615
New +$2.25M 1.8% 26
2015
Q1
Sell
-7,810
Closed -$352K 117
2014
Q4
$352K Buy
+7,810
New +$340K 0.25% 89

Other funds holding ABT

WESPAC Advisors's ABT Position: Q2 2021 in Review

WESPAC Advisors sold out of Abbott (ABT) in Q2 2021, closing a stake of 11,087 shares — an estimated $1.33M sold.

WESPAC Advisors first reported a position in ABT in Q4 2014 and held it in 9 quarters. The position peaked at $2.41M in Q2 2019. 2,503 funds tracked by Wall St. Rank hold ABT as of Q2 2021.

  • WESPAC Advisors reported no remaining Abbott position as of Q2 2021 after selling out during the quarter.
  • WESPAC Advisors sold 11,087 Abbott shares in Q2 2021, an estimated $1.33M.
  • WESPAC Advisors first reported a position in Abbott in Q4 2014 and held it in 9 quarters.
  • WESPAC Advisors's Abbott position peaked at $2.41M in Q2 2019.
  • 2,503 funds tracked by Wall St. Rank held Abbott as of Q2 2021.

Based on WESPAC Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.